Loading clinical trials...
Loading clinical trials...
Phase I/II Study of Allogeneic Stem Cell Transplantation For Patients With Graft Failure Following Allogeneic Transplantation Using MHC Identical or Near Identical Donors and Submyeloablative Conditioning With CAMPATH 1H (CAMGRAFT)
Conditions
Interventions
Fludarabine
CAMPATH 1H
+2 more
Locations
2
United States
Texas Children's Hospital
Houston, Texas, United States
The Methodist Hospital
Houston, Texas, United States
Start Date
December 1, 2000
Primary Completion Date
October 31, 2003
Completion Date
October 31, 2003
Last Updated
January 18, 2020
NCT03541889
NCT07244419
NCT06512545
NCT03272854
NCT04779957
NCT03373227
Lead Sponsor
Baylor College of Medicine
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions